Alan H. Auerbach, President and CEO at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 82,792 shares at $4.49 ($372K) on 2024-01-03, disclosed to the SEC on 2024-01-05.
Scheduled sale ($372k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.49 | 41,396 | $186K | 50.0% |
| 2 | $4.49 | 41,396 | $186K | 50.0% |
| Total | $4.49 avg | 82,792 | $372K | 100% |
| Filing → |
| PBYI | SELL | 2025-07-10 | $333K | — | Filing → |
| PBYI | SELL | 2025-01-03 | $213K | — | Filing → |
| PBYI | SELL | 2024-07-18 | $81K | — | Filing → |